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ABSTRACT 
Background: Limited duration of time has been one of the main drawback of spinal anesthesia.To avoid this. 
adjuvants have been added to the local anesthetic agent and has proven benefits when used intrathecally. Aims and 
Objectives: To compare the effect of intrathecal clonidine 75 µg or neostigmine 50 µg added to intrathecal 
hyperbaric bupivacaine, with respect to sensory characteristics, motor characteristics, haemodynamic stability and 
side effects. Materials and Methods: Our prospective study included 60 patients who were admitted for lower 
abdominal surgeries. The patients were randomly divided into 2 groups, with 30 in each group. Group A patients 
received neostigmine 50 µg with 2.5 ml of intrathecal 0.5% hyperbaric bupivacaine and group B patients received 
intrathecal clonidine 75 µg and 2.5 ml of intrathecal 0.5% hyperbaric bupivacaine. The parameters for comparison 
of 2 groups included sensory characteristics, motor characteristics, haemodynamic stability and side effects. 
Results: In Group B patients, there was a significantly enhanced onset of sensory and motor block and well 
maintained haemodynamics. Group A patients had prolonged analgesia. Perioperatively no serious adverse effects 
were noted in both the groups. Conclusion: Intrathecal clonidine with hyperbaric bupivacaine produces prolonged 
postoperative analgesia and intrathecal neostigmine with bupivacaine produces a good sensory and motor blockade 
for lower abdominal surgeries. 
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Introduction 
 
 
The basic purpose of giving anaesthesia is to provide 
good analgesia with satisfactory muscle relaxation 
throughout the intraoperative period and managing 
pain in the postoperative period. Successful 
management of postoperative pain may decrease 
morbidity and mortality, bring about early 
mobilization, comfort and satisfaction of patients[1,2].
 
Since its introduction in 1898, spinal anesthesia is one 
of the most accepted techniques used for elective and 
emergency procedures like cesarean sections, lower 
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abdominal surgeries, orthopedic and urological 
surgeries. The major advantages of spinal anesthesia 
apart from an awake patient are its simple technique, 
rapid onset of action, nominal drug cost and relatively 
fewer side effects. Intrathecal bupivacaine is the most 
commonly used local anesthetic during subarachnoid 
block. The main disadvantage is the insufficient 
duration of anesthesia and postoperative analgesia 
when used alone. Bupivacaine can be used for 
procedures lasting for about two to two and half years, 
hence for surgeries which require more time, adjuvants 
should be added[3,4].
 
If the dose of intrathecal bupivacaine is increased to 
prolong the duration of the subarachnoid blockade, 
there is a risk of hypotension and bradycardia.Hence in 
order to prolong the duration of bupivacaine and  
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postoperative analgesia, a number of adjuvants have 
been introduced. The other advantages being reduction 
in dose of local anesthetics and reduced side effects[5]. 
Basically adjuvants are pharmacological agents having 
little pharmacological effect by themselves, but can 
enhance or potentiate the action of other drugs when 
given at the same time. Many studies have been carried 
out to find out the efficacy of both opioids and alpha 2 
adrenergic agonists like clonidine as adjuvants to 
intrathecal bupivacaine and found them to be effective. 
Alpha 2 adrenergic agonists have added advantage of 
absence of opioids related side effects like pruritus, 
nausea-vomiting, acute urinary retention and 
sedation[6,7]. 
Clonidine and neostigmine are commonly used as 
adjuvants to bupivacaine. Clonidine is a selective 
partial α2 adrenergic agonist and its activation inhibits 
the central transmission of nociceptive impulses. 
Analgesic effect of clonidine is supposed due to 
inhibition of release of substance P[8]. 
 Whereas the mechanism of analgesic action of 
neostigmine (anticholinesterase agent) is due to 
prevention of the breakdown of synaptically released 
acetylcholine, which acts on muscarinic and nicotinic 
receptors in the spinal cord[9]. 
 We carried our study to compare the effect of 
intrathecal clonidine 75 µg or neostigmine      50 µg 
added to intrathecal hyperbaric bupivacaine, with 
respect to sensory characteristics, motor characteristics, 
haemodynamic stability and side effects. 
 
Material and Methods 
 
We carried our study in 60 patients from December 
2015 to November 2016, after obtaining institutional 
ethical committee approval. Consent was obtained 
from all the patients. Initially 67 patients were enrolled 
in the study. 7 patients were excluded as they did not 
meet the inclusion criteria. 60 patients were divided 
randomly into two groups of thirty each.  
We followed the methodology used by Yoganarasimha 
et al (2014) [1]. Preanaesthetic check up and 
appropriate investigations were performed.  
Group A patients (n=30): Received neostigmine 50 
µg with 2.5 ml of intrathecal 0.5% hyperbaric 
bupivacaine and  
Group B patients (n=30): Received intrathecal 
clonidine 75 µg and 2.5 ml of intrathecal 0.5% 
hyperbaric bupivacaine. 
Inclusion criteria 
1. Patients undergoing lower abdominal surgeries, 
2. Patients above 18 years of age and 
3. Patients not allergic to the study drugs.  
 
Exclusion criteria  
1. Patients with contraindications for spinal 
anaesthesia,  
2. Patients with ischemic heart disease (IHD),  
3. Patients with hypertension,  
4. Patients with bronchial asthma,  
5. Patients with diabetes mellitus and  
6. Morbidly obese patients 
Premedication with tablet ranitidine 150 mg and tablet 
alprazolam 0.5 mg was given to all the patients on the 
night before surgery. Patients were connected to 
multichannel monitor displaying electrocardiogram 
(ECG), oxygen saturation (SPO2) and non-invasive 
blood pressure (NIBP) and readings were recorded. 
Under aseptic conditions, lumbar puncture was 
performed using 26/27 G spinal needle at L3- L4 
space. After confirming the clear free flow of 
cerebrospinal fluid (CSF), the study drugs were 
injected into the sub- arachnoid space at the rate of 1 
ml given in 3 seconds.  
The comparative parameters were noted and they were 
1. Time of onset of analgesia (time taken from the 
injection of the drug to loss of pin prick at T10 
level),  
2. Cephalad spread of analgesia achieved,  
3. Time taken for onset of motor blockade (time 
taken for complete inability to flex both the lower 
limbs at hip joint),  
4. Quality of motor blockade assessed by Bromage 
scale,  
5. Intra operative haemodynamic monitoring (heart 
rate (HR), systolic blood pressure (SBP) measured 
immediately, after 2 minutes, 5 minutes, 
10 minutes and every 5 minutes till the end of 
surgery,  
6. Total duration of analgesia (time from the onset of 
analgesia to the point where the patient 
complained of pain at the surgical site requiring 
rescue analgesics or visual analogue scale 
(VAS)>4),  
7. Duration of motor block (complete recovery of 
motor power) and  
8. Any other side effects associated with the 
administration of intrathecal clonidine and 
neostigmine. 
The data was analysed by SPSS for windows 
(version 17) statistical package(SPSS Inc., 
Chicago, IL). The data were expressed as mean ± 
standard deviation (SD) and analyzed using 
Fischer exact test and Chi square test as required 
and nominal and continuous variables using 
student 't' test. The values of P < 0.05 was 
considered significant. 
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Result 
 
The demographic details and duration of surgery were comparable between the groups    [Table 1]. 
 
Table 1: Demographics and duration of surgery in both the groups 
 
Parameter Group A Group B P value 
Mean age (years) 29.14±9.03 39.42±4.38 <0.0001* 
Mean weight  (Kgs) 58.59±7.02  54.83±9.12 0.0788 
Duration of surgery (minutes) 57.3±11.35  58.19±16.41 0.8078  
<0.0001*=extremely statistically significant.  
 
Graph 1:  demographics and duration of surgery in both the groups 
 
 
Patients in Group A showed early onset of sensory block (101± 12 seconds) compared to group B (165±18 seconds: 
P < 0.001). The cephalad spread of sensory block was similar in both groups. The mean total duration of analgesia 
was prolonged in group B (372±33 min) compared to group A (310 ± 20 minutes: P < 0.001) [Table 2].  
 
Table 2: Sensory characteristics 
 
Parameter Group A Group B P value 
Mean onset time  (seconds) 101±12 165±18 <0.0001* 
Mean total duration of analgesia (minutes)  310±20 372±33  <0.0001* 
Median cephalad spread T4 T4 - 
<0.0001*=Statistically significant.  
Graph 2: Sensory characteristics in both groups 
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Onset of motor block was 165 ±12 seconds in group A, whereas it was 216±36 seconds in group B (P < 0.001). 
Recovery from motor block took 175 ± 40 minutes in group A compared to 215 ± 50 minutes in group B [Table 3]. 
 
Table 3: Motor characteristics in both groups 
 
Parameter Group A Group B P value 
Mean onset time  (seconds) 165±12 216±36 <0.0001* 
Duration of motor blockade (minutes) 175±40 215±50 <0.0001* 
Quality of motor blockade Bromage grade 
III→100% 
Bromage grade 
III→100% 
- 
<0.0001*= Statistically significant. 
 
Graph 3: Motor characteristics in both groups 
 
 
Increase in heart rate was noted in both groups following spinal anaesthesia with mean maximum increase of 18 
beats/minute noted at 5
th
 minute in group A, whereas it showed an increase of 14 beats/minutes noted at 2
nd
 minute 
in group B (Graph 4 and Graph 5) 
 
 
Graph 4: Heart rate comparison 
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Graph 5: Systolic blood pressure comparison 
 
 
 
Discussion 
  
Anaesthetists prefer spinal anesthesia for infra 
umbilical surgeries like hernioplasty, appendicectomy 
and abdominal hysterectomies, as it is the fastest, 
predictable and most reliable form of anesthesia. 
Bupivacaine is the choice for many, as it provides 
some analgesic effect postoperatively, but its main 
disadvantage is short duration of analgesia is not 
lengthy enough to relieve pain for extended period in 
postoperative setting after wearing off of the local 
anesthetic effect[1-3]. 
Anesthetic planning should include pain relief. 
Deleterious effects of pain during surgery or in the 
postoperative period are[1,3,5] 
1. Sympathetic stimulation which results in increased 
heart rate, blood pressure, altered regional blood flow, 
increased oxygen consumption and  
2. Stress response due to hormonal surge and depressed 
immune functions.  
The mechanism of action of clonidine is by spinal 
cholinergic activation acetyl choline to produce 
analgesia. It also blocks Aδ and C fibers at lamina V, 
thus producing analgesia[10,11]. 
Several authors used clonidine in dosages between 15 
µg to 300 µg intrathecally. The maximum dose of 
intrathecal clonidine with local anaesthetics was 1-2 
µg/kg, as higher doses was shown to produce marked 
sedation as well as haemodynamic disturbances[10,12]. 
Strebel et al also reported that small doses of 
intrathecal clonidine (≤ 150 µg) significantly prolong 
the anaesthetic and analgesic effects of bupivacaine in 
a dose dependent manner[10].Hence, we used 75 µg of 
clonidine in our study. We found that the onset of 
sensory blockade was accelerated with the addition of 
neostigmine, suggesting that neostigmine enhances 
action of spinally administered local anaesthetics. The 
mechanism behind this action might be due to 
neostigmine being an acetyl cholinesterase inhibitor, 
inhibits breakdown of the endogenous neurotransmitter 
acetylcholine, thereby inducing analgesia.  Thus it can 
be used as an alternative non opioid additive to local 
anaesthetics without any opioid associated side 
effects[13]. 
Pan et al found that the onset of sensory block was 
rapid in neostigmine group than the clonidine group in 
caesarean patients[14]. We also found similar findings. 
Yoganarasimha et al also found similar findings of 
faster onset of sensory and motor block neostigmine 
when compared to clonidine[1]. 
We also found that the duration of analgesia was 
prolonged with the addition of clonidine when 
compared to that by neostigmine. The mechanism of 
action of clonidine is thought due to prolonging the 
motor blockade produced by local anaesthetic agents 
and also by bringing local vasoconstriction by acting 
on vascular smooth muscle (α-receptors), thereby 
decreasing the absorption of local anaesthetics from 
sub-arachnoid space leading to an increase in the 
duration of action[15,16]. 
According to Liu et al, neostigmine increases spinal 
levels of acetylcholine, thereby augmenting motor 
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block[17].
 
Sethi BS et al showed that addition of 
clonidine to bupivacaine in the dose of 1 µg/kg 
significantly increased the duration of analgesia when 
compared to bupivacaine alone.
7
 Gupta et al reported 
an enhanced analgesia by intrathecal neostigmine in 75 
µg dose as they observed less consumption of 
intramuscular diclofenac sodium[18]. 
We found that the mean time for motor block onset and 
the mean time taken for maximum motor blockade was 
significantly faster in neostigmine group than 
compared to clonidine group. Our findings are in 
accordance with Klamt et al[19]. 
Studies have shown that intrathecal administration of 
neostigmine brings about acetylcholine-induced 
stimulation of preganglionic sympathetic neurons , 
thereby causing an increase in heart rate and blood 
pressure[20,21].We found an increase in heart rate in 
patients receiving intrathecal neostigmine, similar to 
those observed by Klamt et al[19]. 
Studies have shown contradictory findings regarding 
blood pressure changes following various doses of 
intrathecal clonidine. Overall smaller doses of 
clonidine have shown to result in a fall in blood 
pressure by the effect on central brain stem nucleus and 
pre-ganglionic sympathetic inhibition. Whereas, larger 
doses have shown to maintain BP through its effects on 
peripheral vasculature[10,22].
 
We found an increase of 
hypotension following intrathecal administration of 75 
µg of clonidine, but it could be easily managed with 
vasopressors.  
Hood et al showed side effects of nausea and vomiting 
perioperatively after adminstration of intrathecal 
administration of neostigmine. According to them, this 
might be due to rostral spread of neostigmine to the 
brainstem site [21]. We did not noticed any side effects 
in our patients. This might be due to dilution of drug 
with local anaesthetic. We suggest more such studies 
with larger sample size so as to establish the equipotent 
doses of these drugs.  
 
Conclusion 
 
We carried our study to compare the effect of 
intrathecal clonidine 75 µg or neostigmine 50 µg added 
to intrathecal hyperbaric bupivacaine and found that 
neostigmine significantly hastened the onset of sensory 
and motor block without prolonging the duration of 
analgesia compared to clonidine.  
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